Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John Ludes-Meyers
Corrigendum to ‘Targeting FGFR2 With Alofanib (RPT835) Shows Potent Activity in Tumour Models’ [Eur J Cancer 61 (2016) 20–28]
European Journal of Cancer
Cancer Research
Oncology
Related publications
Brivanib in Combination With Notch3 Silencing Shows Potent Activity in Tumour Models
British Journal of Cancer
Cancer Research
Oncology
Graphical Abstract: Chem. Eur. J. 28/2006
Chemistry - A European Journal
Organic Chemistry
Catalysis
Chemistry
Graphical Abstract: Chem. Eur. J. 20/2009
Chemistry - A European Journal
Organic Chemistry
Catalysis
Chemistry
Graphical Abstract: Chem. Eur. J. 20/2004
Chemistry - A European Journal
Organic Chemistry
Catalysis
Chemistry
Graphical Abstract: Chem. Eur. J. 30/2016
Chemistry - A European Journal
Organic Chemistry
Catalysis
Chemistry
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Graphical Abstract: Chem. Eur. J. 32/2016
Chemistry - A European Journal
Organic Chemistry
Catalysis
Chemistry
Graphical Abstract: Chem. Eur. J. 13/2016
Chemistry - A European Journal
Organic Chemistry
Catalysis
Chemistry
TAS4464, a Highly Potent and Selective Inhibitor of NEDD8 Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
